Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: HiSpeed who wrote (10)	9/4/1998 12:54:00 PM
From: Jeffrey L. Henken	Read Replies (2) \| Respond to of 939

Chromatics Color Sciences International Signs Lease and License Agreement with Nordstrom Department Stores NEW YORK, Sept. 4 /PRNewswire/ -- Chromatics Color Sciences International, Inc. (Nasdaq: CCSI - news) has signed a lease and license agreement with Nordstrom Department Stores for use of the Company's technology and Colormate(R) Systems for custom blending cosmetics. The custom blended system and products provided by the Company will be used to formulate and recommend the ''C20 Color to Order(TM)'' line of cosmetic products, Nordstrom's proprietary line of cosmetics, which will be introduced at its 4 flagship stores, where it will be evaluated over a 3 month period for extended use including additional Nordstrom store locations. Nordstrom will use the Colormate(R) II units to analyze individual customers' skin color and recommend custom-blended foundation color formulations to match or enhance their natural skin color, along with appropriate customized shades of blush, lipstick, concealers, eyeshadow and powders. The Company is collaborating on the project with Cosmetiques IV Generations, Ltd., which will provide training and in-store servicing among other functions on the Company's behalf at the Nordstrom launch locations. ''We are very pleased to be working with Nordstrom on this project,'' said Darby Macfarlane, chief executive officer of Chromatics. ''It underscores the potential our proprietary technologies have for the cosmetics and beauty industries.'' Chromatics Color Sciences is in the business of color science and has developed technologies and intellectual properties which it believes have medical applications involving the detection and monitoring of chromogenic diseases or disorders such as bilirubin infant jaundice. The Company defines chromogenic diseases or disorders as those diagnosed or monitored by the coloration of the human skin, tissue or fluid being affected. In this regard the Company has received Food and Drug Administration (FDA) clearance for commercial marketing of its medical device for detection and monitoring of bilirubin infant jaundice. Other medical applications will require additional clinical trials and FDA clearance. The Company's technologies and intellectual properties also have other applications, including the scientific color measurement and classification of human skin, certain color-sensitive consumer products, and in determining the color compatibility of such skin and product color classification for use in a variety of industries including the cosmetic beauty-aid and fashion industries. Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business which may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, the availability of any needed financing, the Company's ability to implement its long range business plan for various applications for its technologies, the impact of competition, the obtaining of further regulatory clearances applicable to proposed new application of the Company's technology, management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchanges Commission, including those set forth in this annual report on Form 10-K for the year ended December 31, 1997. SOURCE: Chromatics Color Sciences International, Inc. biz.yahoo.com Pick #1. This is only the beginning for CCSI. Regards, Jeff